Post hepatectomy liver failure – A comprehensive review of current concepts and controversies

Annals of Medicine and Surgery

Volumn 34, Issue , 2018, Pages 4-10

  Ray, S ^a   Mehta, N N ^a   Golhar, A ^a   Nundy, S ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

Complications; Hepatectomy; Liver transplantation; PHLF; Regeneration

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; CYCLIN D1; INSULIN; INTERLEUKIN 6; NITRIC OXIDE; OXALIPLATIN; PROSTAGLANDIN E2; S ADENOSYLMETHIONINE; SOMATOSTATIN; TUMOR NECROSIS FACTOR;

AGE; ARTIFICIAL EMBOLIZATION; BLOOD TRANSFUSION; CHILD PUGH SCORE; FATTY LIVER; HUMAN; INDOCYANINE GREEN RETENTION RATE; LIVER FAILURE; LIVER FUNCTION TEST; LIVER PERFUSION; LIVER REGENERATION; LIVER RESECTION; LIVER WEIGHT; MODEL FOR END STAGE LIVER DISEASE SCORE; NONHUMAN; OPERATIVE BLOOD LOSS; PATHOPHYSIOLOGY; PORTAL VEIN EMBOLIZATION; PORTAL VEIN LIGATION; PORTOCAVAL SHUNT; POST HEPATECTOMY LIVER FAILURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEPSIS; SPLENECTOMY; STEM CELL TRANSPLANTATION; VEIN LIGATION;

EID: 85054056979     PISSN: 20490801     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amsu.2018.08.012     Document Type: Review

References (77)

1. Zheng, Y., Yang, H., He, L., et al. Reassessment of different criteria for diagnosing post-hepatectomy liver failure: a single-center study of 1683 hepatectomy. Oncotarget 8 (2017), 89269–89277.
2. Schreckenbach, T., Liese, J., Bechstein, W.O., Moench, C., Posthepatectomy liver failure. Dig. Surg. 29 (2012), 79–85.
3. Figueras, J., Valls, C., Rafecas, A., Fabregat, J., Ramos, E., Jaurrieta, E., Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br. J. Surg. 88 (2001), 980–985.
4. Finch, R.J.B., Malik, H.Z., Hamady, Z.Z.R., Effect of type of resection on outcome of hepatic resection for colorectal metastases. Br. J. Surg. 94 (2007), 1242–1248.
5. Karanjia, N.D., Lordan, J.T., Quiney, N., Fawcett, W.J., Worthington, T.R., Remington, J., A comparison of right and extended right hepatectomy with all other hepatic resections for colorectal liver metastases: a ten-year study. Eur. J. Surg. Oncol. 35 (2009), 65–70.
6. Ren, Z., Xu, Y., Zhu, S., Indocyanine green retention test avoiding liver failure after hepatectomy for hepatolithiasis. Hepato-Gastroenterology 59 (2012), 782–784.
7. Balzan, S., Belghiti, J., Farges, O., et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann. Surg. 242 (2005), 824–828 discussion 8–9.
8. Mullen, J.T., Ribero, D., Reddy, S.K., et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J. Am. Coll. Surg. 204 (2007), 854–862 discussion 62–4.
9. Rahbari, N.N., Garden, O.J., Padbury, R., et al. Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS). Surgery (St Louis) 149 (2011), 713–724.
10. Michalopoulos, G.K., Liver regeneration. J. Cell. Physiol. 213 (2007), 286–300.
11. Tu, Z., Bozorgzadeh, A., Pierce, R.H., Kurtis, J., Crispe, I.N., Orloff, M.S., TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 205 (2008), 233–244.
12. Matsumoto, K., Yoshitomi, H., Rossant, J., Zaret, K.S., Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294 (2001), 559–563.
13. Cantré D., Schuett, H., Hildebrandt, A., Nitric oxide reduces organ injury and enhances regeneration of reduced-size livers by increasing hepatic arterial flow. Br. J. Surg. 95 (2008), 785–792.
14. Mortensen, K.E., Conley, L.N., Nygaard, I., Increased sinusoidal flow is not the primary stimulus to liver regeneration. Comp. Hepatol., 9, 2010, 2.
15. Ryan, C.J., Guest, J., Harper, A.M., Blumgart, L.H., Liver blood flow measurements in the portacavally transposed rat before and after partial hepatectomy. Br. J. Exp. Pathol. 59 (1978), 111–115.
16. Taub, R., Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 5 (2004), 836–847.
17. Sakamoto, T., Liu, Z., Murase, N., Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 29 (1999), 403–411.
18. Kawasaki, T., Murata, S., Takahashi, K., Activation of human liver sinusoidal endothelial cell by human platelets induces hepatocyte proliferation. J. Hepatol. 53 (2010), 648–654.
19. Lesurtel, M., Graf, R., Aleil, B., Platelet-derived serotonin mediates liver regeneration. Science 312 (2006), 104–107.
20. Wack, K., Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. Hepatology 33 (2001), 363–378.
21. Petrowsky, H., Breitenstein, S., Slankamenac, K., et al. Effects of pentoxifylline on liver regeneration. Ann. Surg. 252 (2010), 813–822.
22. Belghiti, J., Liddo, G., Raut, V., et al. “Inherent limitations” in donors: control matched study of consequences following a right hepatectomy for living donation and benign liver lesions. Ann. Surg. 255 (2012), 528–533.
23. Timchenko, N.A., Aging and liver regeneration. Trends Endocrinol. Metabol. 20 (2009), 171–176.
24. Kim, J.M., Cho, B.I., Kwon, C.H., et al. Hepatectomy is a reasonable option for older patients with hepatocellular carcinoma. Am. J. Surg. 209 (2015), 391–397.
25. Little, S.A., Jarnagin, W.R., DeMatteo, R.P., Blumgart, L.H., Fong, Y., Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J. Gastrointest. Surg. 6 (2002), 88–94.
26. N.L. Bucher. Insulin, glucagon, and the liver. Adv. Enzym. Regul.;15:221-230.
27. Schindl, M.J., Redhead, D.N., Fearon, K.C., et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 54 (2005), 289–296.
28. Fan, S.T., Lo, C.M., Lai, E.C., Chu, K.M., Liu, C.L., Wong, J., Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N. Engl. J. Med. 331 (1994), 1547–1552.
29. Kaibori, M., Inoue, T., Sakakura, Y., et al. Impairment of activation of hepatocyte growth factor precursor into its mature form in rats with liver cirrhosis. J. Surg. Res. 106 (2002), 108–114.
30. Robinson, S.M., Wilson, C.H., Burt, A.D., Manas, D.M., White, S.A., Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann. Surg Oncol. 19 (2012), 4287–4299.
31. Reddy, S.K., Marsh, J.W., Varley, P.R., et al. Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case–control study. Hepatology 56 (2012), 2221–2230.
32. Vauthey, J.N., Pawlik, T.M., Ribero, D., et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol. 24 (2006), 2065–2072.
33. Mehta, N.N., Ravikumar, R., Coldham, C.A., et al. Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur. J. Surg. Oncol. 34 (2008), 782–786.
34. Overman, M.J., Maru, D.M., Charnsangavej, C., Oxaliplatin mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J. Clin. Oncol. 28 (2010), 2549–2555.
35. Capussotti, L., Muratore, A., Amisano, M., Polastri, R., Bouzari, H., Massucco, P., Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival–a European single center experience. Eur. J. Surg. Oncol. 31 (2005), 986–993.
36. Makuuchi, M., Kosuge, T., Takayama, T., Surgery for small liver cancers. Semin. Surg. Oncol. 9 (1993), 298–304.
37. Imamura, H., Seyama, Y., Kokudo, N., et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch. Surg. 138 (2003), 1198–1206 discussion 206.
38. Fujii, Y., Shimada, H., Endo, I., Risk factors of posthepatectomy liver failure after portal vein embolization. J Hepatobiliary Pancreat. Surg. 10 (2003), 226–232.
39. Emond, J.C., Renz, J.F., Ferrell, L.D., et al. Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann. Surg. 224 (1996), 544–552 discussion 52-4.
40. Li, C., Mi, K., Wen, T.-F., Yan, L.-N., Li, B., Safety of patients with a graft to body weight ratio less than 0.8% in living donor liver transplantation using right hepatic lobe without middle hepatic vein. Hepato-Gastroenterology 59 (2012), 469–472.
41. van den Broek, M.A., Olde Damink, S.W., Dejong, C.H., et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int. 28 (2008), 767–780.
42. Hyder, O., Pulitano, C., Firoozmand, A., et al. A risk model to predict 90-day mortality among patients undergoing hepatic resection. J. Am. Coll. Surg. 216 (2013), 1049–1056.
43. Rahbari, N.N., Reissfelder, C., Koch, M., et al. The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients. Ann. Surg Oncol. 18 (2011), 3640–3649.
44. Kim, S.H., Kang, D.R., Lee, J.G., et al. Early predictor of mortality due to irreversible posthepatectomy liver failure in patients with hepatocellular carcinoma. World J. Surg. 37 (2013), 1028–1033.
45. Skrzypczyk, C., Truant, S., Duhamel, A., et al. Relevance of the ISGLS definition of posthepatectomy liver failure in early prediction of poor outcome after liver resection: study on 680 hepatectomies. Ann. Surg. 260 (2014), 865–870 discussion 70.
46. Zipprich, A., Kuss, O., Rogowski, S., et al. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut 59 (2010), 963–968.
47. Fan, S.T., Lai, E.C., Lo, C.M., Ng, I.O., Wong, J., Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch. Surg. 130 (1995), 198–203.
48. Lam, C.M., Fan, S.T., Lo, C.M., Wong, J., Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br. J. Surg. 86 (1999), 1012–1017.
49. de Liguori Carino, N., O'Reilly, D.A., Dajani, K., Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure. Eur. J. Surg. Oncol. 35 (2009), 957–962.
50. Stockmann, M., Lock, J.F., Riecke, B., et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann. Surg. 250 (2009), 119–125.
51. Hoekstra, L.T., de Graaf, W., Nibourg, G.A., et al. Physiological and biochemical basis of clinical liver function tests: a review. Ann. Surg. 257 (2013), 27–36.
52. Wibmer, A., Prusa, A.M., Nolz, R., Gruenberger, T., Schindl, M., Ba-Ssalamah, A., Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging. Radiology 269 (2013), 777–786.
53. Varma, V., Mehta, N., Kumaran, V., Nundy, S., Indications and contraindications of liver transplantation. Int J Hepatol, 2011, 10.4061/2011/121862.
54. Ribero, D., Chun, Y.S., Vauthey, J.N., Standardized liver volumetry for portal vein embolization. Semin. Intervent. Radiol. 25 (2008), 104–109.
55. Abdalla, E.K., Adam, R., Bilchik, A.J., Jaeck, D., Vauthey, J.N., Mahvi, D., Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann. Surg Oncol. 13 (2006), 1271–1280.
56. Kishi, Y., Abdalla, E.K., Chun, Y.S., et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann. Surg. 250 (2009), 540–548.
57. Hemming, A.W., Reed, A.I., Howard, R.J., et al. Preoperative portal vein embolization for extended hepatectomy. Ann. Surg. 237 (2003), 686–691 discussion 691-3.
58. May, B.J., Madoff, D.C., Portal vein embolization: rationale, technique and current application. Semin. Intervent. Radiol. 29 (2012), 81–89.
59. Capussotti, L., Muratore, A., Baracchi, F., et al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch. Surg. 143 (2008), 978–982 discussion 982.
60. Ogata, S., Belghiti, J., Farges, O., Varma, D., Sibert, A., Vilgrain, V., Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br. J. Surg. 93 (2006), 1091–1098.
61. Narita, M., Oussoultzoglou, E., Jaeck, D., et al. Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br. J. Surg. 98 (2011), 1463–1475.
62. Schnitzbauer, A.A., Lang, S.A., Goessmann, H., et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right. J. Gastrointest. 17 (2013), 593–605.
63. Pandanaboyana, S., Bell, R., Hidalgo, E., et al. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery (St Louis) 157 (2015), 690–698.
64. Mise, Y., Hasegawa, K., Satou, S., et al. Venous reconstruction based on virtual liver resection to avoid congestion in the liver remnant. Br. J. Surg. 98 (2011), 1742–1751.
65. Hoti, E., Salloum, C., Azoulay, D., Hepatic resection with in situ hypothermic perfusion is superior to other resection techniques. Dig. Surg. 28 (2011), 94–99.
66. Azoulay, D., Eshkenazy, R., Andreani, P., Castaing, D., Adam, R., In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann. Surg. 241 (2005), 277–285.
67. Clavien, P.A., Yadav, S., Sindram, D., Bentley, R.C., Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann. Surg. 232 (2000), 155–162.
68. Kanoria, S., Robertson, F.P., Mehta, N.N., Fusai, G., Sharma, D., Davidson, B.R., Effect of remote ischemic preconditioning on liver injury in patients undergoing major hepatectomy for colorectal liver metastasis: a pilot randomised controlled feasibility trial. World J. Surg. 41 (2017), 1322–1330.
69. Alchera, E., Imarisio, C., Mandili, G., et al. Pharmacological preconditioning by adenosine A2a receptor stimulation: features of the protected liver cell phenotype. BioMed Res. Int., 2015 https://doi.org/10.1155/2015/286746.
70. Arakawa, Y., Shimada, M., Uchiyama, H., et al. Beneficial effects of splenectomy on massive hepatectomy model in rats. Hepatol. Res. 39 (2009), 391–397.
71. Troisi, R., Ricciardi, S., Smeets, P., et al. Effects og hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am. J. Transplant. 5 (2005), 1397–1404.
72. Xu, X., Man, K., Zheng, S.S., et al. Attenuation of acute phase shear stress by somatostatin improves small-for-size liver graft survival. Liver Transplant. 12 (2006), 621–627.
73. Chiarla, C., Giovannini, I., Giuliante, F., et al. Plasma bilirubin correlations in non-obstructive cholestasis after partial hepatectomy. Clin. Chem. Lab. Med. 46 (2008), 1598–1601.
74. van de Kerkhove, M.P., de Jong, K.P., Rijken, A.M., de Pont, A.C., van Gulik, T.M., MARS treatment in posthepatectomy liver failure. Liver Int. 23 (2003), 44–51.
75. Demetriou, A.A., Brown, R.S., Busuttil, R.W., Fair, J., McGuire, B.M., Rosenthal, P., et al. Prospective, randomized, multicentre, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 239 (2004), 660–670.
76. Furst, G., Schulte am Esch, J., Poll, L.W., et al. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. Radiology 243 (2007), 171–179.
77. Yamanaka, K., Hatano, E., Narita, M., et al. Olprinone attenuates excessive shear stress through up-regulation of endothelial nitric oxide synthase in a rat excessive hepatectomy model. Liver Transplant. 17 (2011), 60–69.